Why the study?
Does CRT-D improve LVEF and symptoms in a pediatric patient with refractory heart failure and ventricular arrhythmia?
Case Report (n=1)
No
Does CRT-D improve LVEF and symptoms in a pediatric patient with refractory heart failure and ventricular arrhythmia?
Absolute Event Rate: 44% vs 22%
CRT-D may be an effective therapeutic option for improving cardiac function and symptoms in pediatric patients with refractory heart failure and ventricular arrhythmia.
Cardiac resynchronization therapy (CRT) is a new treatment for refractory heart failure. However, most patients with heart failure treated with CRT are adults, middle-aged or older with idiopathic or ischemic dilated cardiomyopathy. We treated a 12-year-old boy, who was transferred after cardiac arrest, with dilated cardiomyopathy, left bundle-branch block, and ventricular tachycardia. We performed cardiac resynchronization therapy with a defibrillator (CRT-D). After CRT-D, left ventricular ejection fraction improved from 22% to 44% assessed by echocardiogram 1 year postoperatively. On electrocardiogram, QRS duration was shortened from 206 to 144 ms. The patient's clinical symptoms also improved. For pediatric patients with refractory heart failure and ventricular arrhythmia, CRT-D could be indicated as an effective therapeutic option.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2016) conducted a case report in Dilated cardiomyopathy with heart failure and ventricular arrhythmia (n=1). Cardiac resynchronization therapy with a defibrillator (CRT-D) vs. Baseline (pre-intervention) was evaluated on Left ventricular ejection fraction (LVEF).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: